5AM raises $285 million fund for early-stage therapeutics and drug delivery

June 7, 2016 – MENLO PARK. 5AM Venture Management, LLC (5AM) of Menlo Park, CA and Boston, MA is pleased to announce the closing of 5AM Ventures V, L.P., a $285 million venture capital fund focused on the building of life science companies.  The capital was raised from a broad range of existing and new institutional investors including endowments, family offices, foundations, funds-of-funds and pension funds.  Since inception, 5AM has raised ~$1 billion for investments in innovative life science companies.

Created by successful industry executives and experienced venture capitalists, the 5AM team takes a focused, hands-on approach to company building. 5AM will continue to target early-stage life science companies with investments focused on the discovery and development of therapeutics, drug delivery technologies and research instruments and reagents.    Within each sector, the firm will invest across various therapeutic areas and will consider opportunities based on innovative platform technologies, corporate spinoffs and products with shorter development cycles.

SOURCE: 5AM